BE826935A - Compositions pharmaceutiques antivirales - Google Patents

Compositions pharmaceutiques antivirales

Info

Publication number
BE826935A
BE826935A BE154548A BE154548A BE826935A BE 826935 A BE826935 A BE 826935A BE 154548 A BE154548 A BE 154548A BE 154548 A BE154548 A BE 154548A BE 826935 A BE826935 A BE 826935A
Authority
BE
Belgium
Prior art keywords
pharmaceutical compositions
antiviral pharmaceutical
antiviral
compositions
pharmaceutical
Prior art date
Application number
BE154548A
Other languages
English (en)
French (fr)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE826935A publication Critical patent/BE826935A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D475/00—Heterocyclic compounds containing pteridine ring systems
    • C07D475/06—Heterocyclic compounds containing pteridine ring systems with a nitrogen atom directly attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48—Two nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BE154548A 1975-02-13 1975-03-20 Compositions pharmaceutiques antivirales BE826935A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB6173/75A GB1530912A (en) 1975-02-13 1975-02-13 Compositions containing 9-(2-hydroxy-3-alkyl)-adenines

Publications (1)

Publication Number Publication Date
BE826935A true BE826935A (fr) 1975-09-22

Family

ID=9809759

Family Applications (1)

Application Number Title Priority Date Filing Date
BE154548A BE826935A (fr) 1975-02-13 1975-03-20 Compositions pharmaceutiques antivirales

Country Status (10)

Country Link
US (1) US4315920A (xx)
AT (1) AT343276B (xx)
BE (1) BE826935A (xx)
CA (1) CA1054521A (xx)
DE (1) DE2512609A1 (xx)
GB (1) GB1530912A (xx)
IN (1) IN141900B (xx)
NZ (1) NZ176971A (xx)
ZA (1) ZA751650B (xx)
ZM (1) ZM5975A1 (xx)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0871449A4 (xx) * 1996-02-12 1998-10-21

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4451478A (en) * 1982-03-12 1984-05-29 Newport Pharmaceuticals International, Inc. Imidazole compounds
DE3323621A1 (de) * 1982-07-08 1984-03-01 Yamasa Shoyu K.K., Choshi, Chiba Pharmazeutisches praeparat mit die antitumor-wirkung verstaerkender wirkung, ein solches praeparat enthaltende chemotherapeutische zusammensetzung und verwendung des praeparates zur unterstuetzung der antitumor-behandlung beim menschen und tier
US6338963B1 (en) 1994-07-25 2002-01-15 Neotherapeutics, Inc. Use of carbon monoxide dependent guanylyl cyclase modifiers to stimulate neuritogenesis
AU3786299A (en) 1998-05-04 1999-11-23 Neotherapeutics, Inc. Novel serotonin-like 9-substituted hypoxanthine and methods of use
US6579857B1 (en) * 1999-06-11 2003-06-17 Evanston Northwestern Healthcare Research Institute Combination cancer therapy comprising adenosine and deaminase enzyme inhibitors
US6297226B1 (en) 1999-10-15 2001-10-02 Neotherapeutics, Inc. Synthesis and methods of use of 9-substituted guanine derivatives
US6407237B1 (en) 2001-02-21 2002-06-18 Neotherapeutics, Inc. Crystal forms of 9-substituted hypoxanthine derivatives
US6849735B1 (en) 2000-06-23 2005-02-01 Merck Eprova Ag Methods of synthesis for 9-substituted hypoxanthine derivatives
ATE499103T1 (de) 2000-07-07 2011-03-15 Spectrum Pharmaceuticals Inc Verfahren zur behandlung von arzneimittelinduzierter peripherer neuropathie und verwandten krankheitsformen
US6759427B2 (en) 2001-04-20 2004-07-06 Spectrum Pharmaceuticals, Inc. Synthesis and methods of use of tetrahydroindolone analogues and derivatives
US20030055249A1 (en) * 2001-07-17 2003-03-20 Fick David B. Synthesis and methods of use of pyrimidine analogues and derivatives

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0871449A4 (xx) * 1996-02-12 1998-10-21

Also Published As

Publication number Publication date
DE2512609A1 (de) 1976-08-26
CA1054521A (en) 1979-05-15
AU7934275A (en) 1976-09-23
AT343276B (de) 1978-05-26
ZA751650B (en) 1976-10-27
US4315920A (en) 1982-02-16
NZ176971A (en) 1984-07-31
GB1530912A (en) 1978-11-01
ZM5975A1 (en) 1977-01-21
IN141900B (xx) 1977-04-30
ATA207275A (de) 1977-09-15

Similar Documents

Publication Publication Date Title
BE852444A (fr) Compositions pharmaceutiques anti-inflammatoires
BE840307A (fr) Carbodimides
FR2300554A1 (fr) Compositions vitaminiques
IT1068132B (it) Composizioni fotopolimerizzabili
BE851590A (fr) Compositions pharmaceutiques renfermant des pyrethrinoides
SE7711395L (sv) Farmaceutisk komposition
BE864359A (fr) Compositions pharmaceutiques antioestrogenes
SE7607620L (sv) Aldohexuronsyra-sotningskompositioner
BE826935A (fr) Compositions pharmaceutiques antivirales
DK153811C (da) Rodenticidt praeparat
BE839209A (fr) Agent antiviral
BE843724A (fr) Compositions odorantes
SE7608478L (sv) Farmaceutica
SE7613364L (sv) Kompositioner
BE870265A (fr) Compositions pharmaceutiques anti-inflammatoires
IT7849938A0 (it) Composizioni farmaceutiche
FR2326189A2 (fr) Composition pharmaceutique
BR7606138A (pt) Composicoes termoendureciveis
BE838507A (fr) Comprimes pharmaceutiques
SE7705658L (sv) Farmaceutisk komposition
RO70928A (ro) Compozitii erbicide sinergetice
FR2336921A1 (fr) Compositions pharmaceutiques anti-inflammatoires
SE7606190L (sv) Polyetenkompositioner
IT1065799B (it) Preparazione di citrale
AT353973B (de) Kosmetischer wirkstoff

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: THE WELLCOME FOUNDATION LTD

Effective date: 19870331